New Comirnaty COVID-19 vaccine in Singapore is made in same way as Pfizer-BioNTech
SINGAPORE — Singapore will soon be receiving a new batch of COVID-19 vaccines called Comirnaty, which is the same as the Pfizer-BioNtech vaccines used in the national vaccination programme.
The Ministry of Health (MOH) said in a media release on Wednesday (23 June) that these vaccines have the same research name - BNT162b2 - as the Pfizer-BioNTech ones, and are manufactured according to the same processes and procedures.
The Comirnaty vaccines also meet the same finished product specifications as the Pfizer-BioNTech vaccines, and are similarly manufactured in Europe and shipped directly to Singapore.
"The only difference is in their label," MOH said.
The ministry will therefore be adjusting the HealthHub records of those who have received, or will be receiving, the Pfizer-BioNTech or Comirnaty vaccines. The records will now be under the "Pfizer-BioNTech/Comirnaty" category.
Moderna is the other mRNA (messenger ribonucleic acid) vaccine used in Singapore and approved by the Health Sciences Authority (HSA).
The Sinovac vaccine remains unregistered in the Republic, and while it is not authorised by the HSA for use under the Pandemic Special Access Route, it can be administered at 24 approved private healthcare clinics.
As at last Saturday, more than half the Singapore population have received at least one dose of the Covid-19 vaccines.
Stay in the know on-the-go: Join Yahoo Singapore's Telegram channel at http://t.me/YahooSingapore
More Singapore stories:
SHN cut from 21 to 14 days for travellers to Singapore from higher-risk regions
Woman filmed hurling racial insults on public bus jailed 4 weeks
Freida Lim is first female Singaporean diver to earn Olympic nod
